PhaseWell Expands Northeast Presence with Chase Acquisition
Hartford News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
PhaseWell Research, a clinical trial company, expands its Northeast presence by acquiring Chase Medical Research. Chase, with over two decades of experience in various health areas, will contribute its expertise in cardiometabolic and central nervous system trials. The partnership aims to bring more advanced trials to Connecticut patients and broaden Chases reach, enhancing options in key health areas nationwide.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/034d592560d56882